Date: 2012-01-05
Type of information: Private placement
Company: Midatech (UK)
Investors:
Amount: £6.3 Million (€7.6 million)
Funding type: private investment
Planned used: This financing will be used to strengthen and diversify Midatech’s product development portfolio, especially in oncology. It will be used to support clinical development of chemotherapeutic gold nanoparticles designed to target ovarian, lung and breast carcinoma and to support development of therapeutic cancer vaccines in SynTara, a joint venture with Immunotope Inc. The funding will also be used to expand the capacity of Midatech’s resources to accommodate its expanding development portfolio.
Others:
Therapeutic area: Cancer - Oncology